XT
BLUE

XTX Topco’s bluebird bio BLUE Stock Holding History

XTX Topco’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,895
Closed -$330K – 1889
2024
Q1 		$330K Buy
12,895
+11,948
+1,262% +$306K 0.04% 769
2023
Q4 		$26.1K Buy
+947
New +$57.7K 0.01% 1330
2022
Q1 		– Sell
-836
Closed -$167K – 684
2021
Q4 		$167K Buy
+836
New +$197K 0.09% 397
2021
Q3 		– Sell
-1,065
Closed -$441K – 704
2021
Q2 		$441K Buy
+1,065
New +$422K 0.15% 219

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's BLUE Position: Q2 2024 in Review

XTX Topco sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 12,895 shares — an estimated $330K sold.

XTX Topco first reported a position in BLUE in Q2 2021 and held it in 4 quarters. The position peaked at $441K in Q2 2021. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • XTX Topco reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • XTX Topco sold 12,895 bluebird bio shares in Q2 2024, an estimated $330K.
  • XTX Topco first reported a position in bluebird bio in Q2 2021 and held it in 4 quarters.
  • XTX Topco's bluebird bio position peaked at $441K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.